Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05827068 · ClinicalTrials.gov registry record · Phase 1

A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults

A Phase 1 study of Seasonal Influenza, sponsored by ModernaTX.

Completed
Registry status
Phase 1
Development phase
698
Enrollment target
20
Study locations

NCT05827068 is a Phase 1 study of Seasonal Influenza that has completed, run by ModernaTX. The registered enrollment target is 698 participants, above the 218-participant average among 3 other Seasonal Influenza trials with a reported enrollment target (220% higher). The trial reports 20 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05827068, a Phase 1 study of Seasonal Influenza, has completed, sponsored by ModernaTX.

COMPLETED
Registry status
Phase 1
Development phase
698 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to measure the safety and the immune response to 3 next-generation influenza vaccine candidates (mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1) compared with influenza vaccine candidate mRNA-1010 controls in healthy adult participants.

Conditions Studied

Seasonal Influenza

Interventions

  • BIOLOGICAL mRNA-1010
  • BIOLOGICAL mRNA-1011.1
  • BIOLOGICAL mRNA-1011.2
  • BIOLOGICAL mRNA-1012.1
  • BIOLOGICAL mRNA-1010.2

Study Locations (20)

Florida

  • CenExel RCA - Hollywood
  • Suncoast Research Associates, LLC - Miami
  • CenExel FCR - Tampa

Missouri

  • DelRicht Research - Springfield
  • Sundance Clinical Research, LLC - St Louis
  • DelRicht Research - Town and Country

California

  • Long Beach Research Institute - Lakewood
  • Long Beach Clinical Trials - Long Beach

Colorado

  • Tekton Research - Fort Collins
  • Critical Care, Pulmonary and Sleep Associates / CCT Research - Lakewood

Maryland

  • CenExel CBH - Gaithersburg
  • DelRicht Research - Rockville

Oklahoma

  • Tekton Research - Edmond
  • Tekton Research - Moore

Georgia

  • Georgia Clinic / CCT Research - Norcross

Nebraska

  • Meridian Clinical Research, LLC - Omaha

Trial Details

FieldValue
Enrollment Target 698 participants
Start Date 2023-03-27
Est. Completion 2023-11-20
Phase Phase 1

Sponsor

ModernaTX

90 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05827068

The ClinicalTrials.gov registry entry for NCT05827068 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 698 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 218-participant average among 3 other Seasonal Influenza trials with a reported enrollment target (220% higher). The listed sponsor is ModernaTX, which has 90 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Seasonal Influenza appearing as the primary indexed condition, and to 5 interventions - of which mRNA-1010 is the first listed.

NCT05827068 reports 20 study locations spanning 12 distinct geographic areas - top geographies include Florida, Missouri, California.

Frequently Asked Questions

What is clinical trial NCT05827068 about?

NCT05827068 is a clinical study titled "A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults". The purpose of this study is to measure the safety and the immune response to 3 next-generation influenza vaccine candidates (mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1) compared with influenza vaccine candidate mRNA-1010 controls in healthy adult participants.

What is the current status of trial NCT05827068?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 698 participants. The study started on 2023-03-27. Estimated completion is 2023-11-20.

What conditions does trial NCT05827068 study?

This clinical trial studies the following conditions: Seasonal Influenza.

What interventions are being tested in trial NCT05827068?

The interventions under investigation include: mRNA-1010 (BIOLOGICAL), mRNA-1011.1 (BIOLOGICAL), mRNA-1011.2 (BIOLOGICAL), mRNA-1012.1 (BIOLOGICAL), mRNA-1010.2 (BIOLOGICAL).

Who is sponsoring clinical trial NCT05827068?

This trial is sponsored by ModernaTX, which has 90 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05827068 being conducted?

This trial has 20 study locations across California, Colorado, Florida, Georgia, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Seasonal Influenza

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Seasonal Influenza

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.